Further to letter dated May 08, 2025, Divis Laboratories has informed that the Board of Directors of the Company at its meeting held on May 17, 2025, has approved the following items of business: Financial Results Approved the Statement of Audited Financial Results, Standalone and Consolidated, for the quarter and year ended March 31, 2025; Recommended a final dividend of ?30 (i.e. 1,500%) per equity share of face value ?2 each for the financial year 2024-25, subject to approval of the members at the ensuing 35th Annual General Meeting (AGM). The dividend shall be paid within specified timelines from the conclusion of the AGM. The 35th AGM of the Members of the Company will be held on Monday, August 11, 2025. The record date for the purpose of the payment of dividend is July 25, 2025.
The above information is a part of company’s filings submitted to BSE.
